RESP royal college Flashcards
what does the diagnosis of asthma require ?
- Variable sx ( cough, chest tightness, dyspnea) which vary overtime and intensity
- Variable exam : confirmed variable expiratory flow limitation
what do you need diagnose asthma
need a spirometry
which subtype of asthma requires higher ICS ?
adult onset
which subtype of asthma is less responsive to ICS
non allergic type
which subtype of asthma could have paucigranulocytic inflammation
non allergic
which type of asthma is associated with little eosinophilic inflammation?
obesity
which type o fasthma is assocxaited with eosinophilic inflammation
both allergic and non allergic
how can variability be demonstrated via asthma testing ?
- BD reversibility ( FEV1>12% and 200 ml post BD)
- lung function w/ antiinflam x 4w ( FEV1>12% and 200 ml post BD)
- excessive FEV 1 variation in lung function between visits ( FEV1>12% and 200 ml post BD)
- peak flow variability ( average daily diurnal PEF variability >10% ; excessive variability in twice daily PEF over 2w)
- bronchial challenge test or exercise challenge test ( methacholine challenge)
what if you have a normal spirometry ? does that rule out asthma
no
what can you do if your spirometry test is normal
- test during sx
- methacholine/exercise tes
what is a + methacholine test
basically if you have a drop in fev1 of 20% with 4 mg/ml of methacholine
what is a (-) methacholine test
if you have a drop of fev1 >20% if require 20 mg/ml of methacholine
what is a + exercise challenge
drop in fev1 >10% and >200ml from baselien
what are the 9 criterias required for asthma control in terms of
1. Daily sx
2. Nighttime sx
3. physical activity
4. exacerbation
5. absence from work/school bcs exacerbation
6. need a reliever ( saba/ bud-form)
7. FEV1 or PEF
8. PEF diurnal variation
9. Sputum eosnophils
- <2
- <1
- Normal
- Mild ( no steroids, no ED) + infrequent
- none
- <2
- > 90% of personal best
- <10-15%
- <2-3%
overuse of SABA is described as what ?
requiring use of 2 SABA inhalers ( bottles i guess) per year
what is a risk for severe exacerbation
- hx of previous severe asthma exacerbation ( systemic steroids/ed/hospit) 2. poorly controlled per criterias
- overuse of SABA ( used 2 in last year)
- current smoker
what is a severe asthma exacerbation vs mild
any asthma episode requiring
1. hospitalisation
2. ed visit
3. systemic steroids
mild= 0/3 criteria
so based on cts management graphic how do you go stepwise
- confirm dx
- enviro control/education/written action plan
- PRN Saba or PRN bud-form
- ICS ( 2nd line LTRA)
5A. add LABA ( >12)
5B . increase ICS ( 6-11)
6A. add LTRA ( >12)
6b . add LABA /LTRA ( 6-11)
Can use LABA in monotherapy? yes, no ? why
noooo
Increased risk of death
what’s the main difference between CTS and GINA
well gina seems to like combining ICS-LABA, prescrisely ICS-formoterol and basically incrase in dose
- start with PRN in step 1 and step 2
- then move to low dose maintenance in step 3
- medium dose maintenance as step 4
- step 5 : erquest phenotype assessment , LAMA, add on +/- anti IGE , anti IL5, anti IL4 , anti TSLP. consider high dose ICS forometerol
why do we love formeterol containing ICS compared to other LABAs?
bcs fast onset of action
compared to SABA alone, why is PRN ICS formoterol better ?
- less exacerb
- less sx
- less hospit
compared to ICS+SABA PRN, why is PRN ICS formoterol better ?
- exacerbation is similar
- less er visit
- less hospit
meds to avoid in asthma
- nsaid
- bb
in what scenario is LTRA great in asthma
- Aspirin induced
- allergic rhinitis
- exercise induced
LTRA vs ICS, in what way is LTRA less effective
less effective in preventing exacerbations
blackbox LTRA warning
increased suicidality
if you have samter’s triad, what should you try
LTRA
what’s samter’s triad again
ASA allergy
nasal polyp
asthma
when to consider AI investigation in asthma management
- maintenance oral cortico
- high dose ICS-LABA
if periph eo >0.3, what else should you do
consider non asthma dx, ie strongyloides, esp before corticosteroids systemic
if periph eo >1.5, what should consider
dx such as egpa
now , if have severe severe ashtma, what are the option considered in CTS 2017 ( and GINA 2024)
- tiotropium mist inhaler
- oral corticosteorid
- macrolides
- bronchial thermoplasty
- biologics
biological option if allergic asthma w/ high IgE
omalizumab ( anti IgE)
bio option if eo allergic asthma
all others
- IL5 ( i..e mepolizumab)
- IL4-IL13 (i.e. Dupilumab )
which ICS has most evidence in pregnancy
budesonide
asthma associated with what in pregnancy
- preterm
- preeclampsia
- low birth weght
- perinatal mortality
ABPA
- major criteria
- minor criteria
major :
- predispo condition : athnma, cf, copd, bronchiectasis
- serum ige >500 or a fumigatus specific ige >0.35
minor ( 2/3)
- periph eo >500
- + IgG against a fumigatus
- fleeting opactiies on CXR
tx of ABPA
pred +/- itraconazole
differentiate rads ( reactive airway dysfunction) from vocal cord dysfunctionm?
rads will have abN methacholine test
asthma exacerbation tx primary care
salbutamol , systemic corticosteroids, o2 supplementation
asthma exacerbation in ed/ er tx
saba,atrovent, o2, steroids
+/- mg
-/- high dose ICS ( methylprednisolone 125 mg IV)
when would lung volume reduction surgery might potentially be useful in COPD ?
- if fev1 <45% and significant gas trapping
Smoking cessation in COPD : how beneficial is it ?
increased survival for all , decreased rate of decline in fev 1
long term o2 therapy : survival benefit in who ?
those with severe resting hypoxemia
what does severe hypoxemia mean in terms of offering o2
- PaO2 <55
- PaO2 <60 w/ bilateral ankle edema , cor pulmonale or hct >56%
what does the NOTT trial 1980 say ? reduces what ???
those with copd and severe hypoxemia : continuous o2 reduces mortality compared to nocturnal o2 alone !!!!
what about giving LTOT in exercise ? what does the NEJM LOTT trial say ?
if stable copd and resting 89-93% or exercise induced desat –> LTOT did not result in longer time to death or first hospit comparefd to no LTOT
pulmo rehab : when does it decrease exacerbation ? what else does it increase ?
if started following recent <4 weeks AECOPD
Increased survival
other pharrm and non pharm tx with survival benefits since 2024
- NIV
- LAMA/LABA/ICS
what mrc dyspnea level is this : stops for breath after walking about 100 m or after a few min on the level
mmrc 3
what mmrc level is this : SOB breath when hurrying on level or walking up straight hill
1
what mmrc level is this : walks slower than people of same age on level b/c of breathlessness or has to stop for breath when walking at own pace on the level
2
what’s mild copd . what’s the tx
cat <10, mmrc 1
fev 1 >80
tx : lama or laba
whats the mod-severe tx if low aecopd risk ?
laba/lama –> laba/lama/ics
whats the mod-severe tx if high aercopd risk
laba/lama/ics –> + macrolide, pde4 inhb, mucolytic agents
high risk aecopd defined as what.
> 2 exacerbation or >1 requiring hospit
low risk of aecopd means what
<1 exacerbation, no ed/hospit
what does cts recommend downstepping back to lama-laba once start lama-laba-ics in a mod-severe high risk aecopd ?
bcs withdrawing ics could lower health status and lung function